SD-169 is an orally active ATP-competitive inhibitor of p38alpha MAPK, with an IC50 of 3.2 nM. SD-169 also weakly inhibits p38beta MAPK with an IC50 of 122 nM. SD-169 prevents the development and progression of diabetes by inhibiting T cell infiltration and activation[1].
Molecular Weight:
160.18
Purity:
99.44
CAS Number:
[1670-87-7]
Formula:
C9H8N2O
Target:
p38 MAPK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted